Helen Tang
- A Phase 2, double-blind, placebo-controlled study of N–acetylcysteine in combination with pirfenidone in patients with idiopathic pulmonary fibrosisBy Jürgen Behr, Elisabeth Bendstrup, Bruno Crestani, Andreas Günther, Horst Olschewski, Magnus Skoeld, Athol Wells, Wim Wuyts, Helen Tang, Jürgen Beck and Carlo AlberaJürgen Behr1Department Internal Medicine V, University of Munich and Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Munich, GermanyElisabeth Bendstrup2Department of Clinical Medicine - The Department of Pulmonary Medicine, Aarhus University, Aarhus C, DenmarkBruno Crestani3Department of Pulmonology, CHU Paris Nord-Val de Seine - Hôpital Xavier Bichat-Claude Bernard, Paris, FranceAndreas Günther4Medical Clinic II, Universitätsklinikum Giessen, Giessen, GermanyHorst Olschewski5Department of Internal Medicine, Division of Pulmonology, Medical University of Graz, Graz, AustriaMagnus Skoeld6Department of Medicine, Solna, Karolinska Institutet, Stockholm, SwedenAthol Wells7Interstitial Lung Diseases Unit, Royal Brompton & Harefield NHS Foundation Trust, London, United KingdomWim Wuyts8Unit for Interstitial Lung Diseases, Department of Pulmonology, University Hospitals Leuven, Leuven, BelgiumHelen Tang9Biostatistics, InterMune, Inc., Brisbane, CA,Jürgen Beck10Clinical Operations Europe, InterMune IAG, Muttenz, SwitzerlandCarlo Albera11Department of Clinical and Biological Sciences, University of Turin, Orbassano (Turin), Italy
- LATE-BREAKING ABSTRACT: Safety and tolerability of N-acetylcysteine (NAC) with pirfenidone in idiopathic pulmonary fibrosis (IPF): PANORAMABy Jrgen Behr, Elisabeth Bendstrup, Bruno Crestani, Andreas Gnther, Horst Olschewski, Magnus Skld, Athol Wells, Wim Wuyts, Dirk Koschel, Michael Kreuter, Benoit Wallaert, Helen Tang, Jrgen Beck and Carlo AlberaJrgen Behr1Department of Internal Medicine V, University of Munich, and Asklepios Clinic Gauting, Member of the German Center for Lung Research, Munich, GermanyElisabeth Bendstrup2Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, DenmarkBruno Crestani3Service de Pneumologie A, Hopital Bichat, Paris, FranceAndreas Gnther4University of Giessen, Agaplesion Lung Clinic Greifenstein, Member of the German Center for Lung Research, Giessen, GermanyHorst Olschewski5Department of Internal Medicine, Division of Pulmonology, Medical University of Graz, Graz, AustriaMagnus Skld6Department of Medicine, Karolinska Institutet, Stockholm, SwedenAthol Wells7Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomWim Wuyts8Department of Respiratory Medicine, University Hospitals Leuven, Leuven, BelgiumDirk Koschel9Department of Internal Medicine/Pulmonology, Fachkrankenhaus Coswig, Coswig, GermanyMichael Kreuter10Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg and Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research, Heidelberg, GermanyBenoit Wallaert11Service de Pneumologie et Immuno-Allergologie, Hopital Albert Calmette, Lille, FranceHelen Tang12InterMune, Roche, Brisbane, CA United StatesJrgen Beck13InterMune, Roche, Basel, SwitzerlandCarlo Albera14Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.